Home6541 • TPE
add
Tanvex Biopharma Inc
Previous close
$65.50
Day range
$62.40 - $65.10
Year range
$35.05 - $80.00
Market cap
10.34B TWD
Avg Volume
261.38K
P/E ratio
-
Dividend yield
-
Primary exchange
TPE
Market news
Financials
Income Statement
Revenue
Net income
| (TWD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 11.50M | 125.33% |
Operating expense | 300.94M | -41.16% |
Net income | -318.46M | 36.98% |
Net profit margin | -2.77K | 72.03% |
Earnings per share | — | — |
EBITDA | -267.94M | 43.67% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (TWD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 742.10M | -15.07% |
Total assets | 2.99B | -13.17% |
Total liabilities | 1.84B | -11.14% |
Total equity | 1.15B | — |
Shares outstanding | 164.07M | — |
Price to book | 9.36 | — |
Return on assets | -23.07% | — |
Return on capital | -24.48% | — |
Cash Flow
Net change in cash
| (TWD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -318.46M | 36.98% |
Cash from operations | -232.65M | 25.04% |
Cash from investing | 118.95M | 337.38% |
Cash from financing | -36.18M | -60.23% |
Net change in cash | -168.23M | 51.39% |
Free cash flow | -115.87M | 30.92% |
About
Founded
2013
Website
Employees
139
